NASDAQ · Medical - Instruments & Supplies

ZJYL (ZJYL) Stock

$2.05 +6.77% NASDAQ: ZJYL Healthcare

Valuation

MetricValue
Price$2.05
Market Cap$16.05M
P/E Ratio15.67
P/B Ratio0.61
P/S Ratio0.87
EPS (TTM)$0.15
52-Week High$17.18
52-Week Low$1.64
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE3.33%
ROA1.89%
ROCE3.45%
Gross Margin4.76%
Operating Margin4.76%
Net Margin5.76%
Debt/Equity0.64
Current Ratio1.83

Annual Financials (USD)

Metric20212022202320242025
Revenue$21.0M$19.0M$20.0M$24.0M$21.0M
Operating Profit$3.0M$2.0M$3.0M$4.0M$1.0M
Net Profit$3.0M$3.0M$3.0M$4.0M$1.0M
EPS$0.20$0.40$0.40$0.47$0.15
Op Margin12.7%11.1%14.5%15.5%2.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$21.0M$33.0M$46.0M$53.0M
Total Liabilities$8.0M$6.0M$9.0M$17.0M$24.0M
Cash$4.0M$5.0M$7.0M$8.0M$7.0M
Borrowings$0$0$4.0M$12.0M$19.0M

Latest News

Top Premarket Gainers MT Newswires · Aug 5, 2026 JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results PR Newswire · Aug 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$6.0M$2.0M$3.0M$-1.0M$3.0M
Investing Cash Flow$-1.0M$0$-8.0M$-11.0M$-17.0M
Financing Cash Flow$0$0$-5.0M$4.0M$0
Net Cash Flow$2.0M$1.0M$2.0M$1.0M$-1.0M
Free Cash Flow$6.0M$2.0M$3.0M$-2.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA30.39
FCF Yield-20.79%
Quick Ratio1.65
Interest Coverage—
Return 1Y-84.87%
Return 3Y-81.63%
Return 5Y—

Ownership

Insiders Held86.95%
Institutions Held0.06%
Institutions Float Held0.49%
Institutional HolderSharesReport Date
Osaic Holdings Inc.3,1002026-03-31
UBS Group AG1,2232026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About ZJYL

ZJYL is led by CEO Erqi Wang, employs 269 people, headquartered in CN, publicly traded since 2023.

ZJYL stock trades at $2.05 with a market capitalization of $16.05M. The stock is valued at a price-to-earnings (P/E) ratio of 15.67, price-to-book of 0.61, price-to-sales of 0.87. Over the past 52 weeks the stock has ranged between $1.64 and $17.18, and currently trades 88.1% below its 52-week high.

On profitability, ZJYL generates a return on equity (ROE) of 3.33%, return on capital employed of 3.45%, an operating margin of 4.76%, a net profit margin of 5.76%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides